• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏附素-1 和乙酰肝素酶在癌症和炎症中的作用。

Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation.

机构信息

Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Department of Gynecology and Obstetrics, Münster University Hospital, Münster, Germany.

出版信息

Adv Exp Med Biol. 2020;1221:97-135. doi: 10.1007/978-3-030-34521-1_4.

DOI:10.1007/978-3-030-34521-1_4
PMID:32274708
Abstract

The cell surface heparan sulfate proteoglycan Syndecan-1 acts as an important co-receptor for receptor tyrosine kinases and chemokine receptors, and as an adhesion receptor for structural glycoproteins of the extracellular matrix. It serves as a substrate for heparanase, an endo-β-glucuronidase that degrades specific domains of heparan sulfate carbohydrate chains and thereby alters the functional status of the proteoglycan and of Syndecan-1-bound ligands. Syndecan-1 and heparanase show multiple levels of functional interactions, resulting in mutual regulation of their expression, processing, and activity. These interactions are of particular relevance in the context of inflammation and malignant disease. Studies in animal models have revealed a mechanistic role of Syndecan-1 and heparanase in the regulation of contact allergies, kidney inflammation, multiple sclerosis, inflammatory bowel disease, and inflammation-associated tumorigenesis. Moreover, functional interactions between Syndecan-1 and heparanase modulate virtually all steps of tumor progression as defined in the Hallmarks of Cancer. Due to their prognostic value in cancer, and their mechanistic involvement in tumor progression, Syndecan-1 and heparanase have emerged as important drug targets. Data in preclinical models and preclinical phase I/II studies have already yielded promising results that provide a translational perspective.

摘要

细胞表面硫酸乙酰肝素蛋白聚糖连接蛋白-1 作为受体酪氨酸激酶和趋化因子受体的重要共受体,以及细胞外基质结构糖蛋白的黏附受体发挥作用。它可作为内切-β-葡糖醛酸酶(heparanase)的底物,后者可降解硫酸乙酰肝素碳水化合物链的特定结构域,从而改变蛋白聚糖和连接蛋白-1 结合配体的功能状态。连接蛋白-1 和肝素酶之间存在多种功能相互作用,导致它们的表达、加工和活性相互调节。这些相互作用在炎症和恶性疾病的背景下具有特殊的意义。动物模型研究揭示了连接蛋白-1 和肝素酶在调节接触过敏、肾脏炎症、多发性硬化、炎症性肠病和炎症相关肿瘤发生中的机制作用。此外,连接蛋白-1 和肝素酶之间的功能相互作用调节了癌症定义的几乎所有肿瘤进展步骤。由于它们在癌症中的预后价值及其在肿瘤进展中的机制参与,连接蛋白-1 和肝素酶已成为重要的药物靶点。临床前模型和临床 I/II 期研究的数据已经产生了有前景的结果,提供了转化的视角。

相似文献

1
Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation.黏附素-1 和乙酰肝素酶在癌症和炎症中的作用。
Adv Exp Med Biol. 2020;1221:97-135. doi: 10.1007/978-3-030-34521-1_4.
2
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.乙酰肝素酶降解syndecan-1和基底膜聚糖硫酸乙酰肝素:对肿瘤细胞侵袭的功能影响
J Biol Chem. 2004 Feb 27;279(9):8047-55. doi: 10.1074/jbc.M304872200. Epub 2003 Nov 20.
3
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.肝素酶/黏附素-1 轴在癌症中的作用:机制与治疗。
FEBS J. 2013 May;280(10):2294-306. doi: 10.1111/febs.12168. Epub 2013 Mar 4.
4
Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.肝癌细胞中乙酰肝素酶-1诱导硫酸乙酰肝素从syndecan-1脱落,通过VEGF-C/ERK途径促进淋巴管内皮细胞增殖。
Biochem Biophys Res Commun. 2017 Apr 1;485(2):432-439. doi: 10.1016/j.bbrc.2017.02.060. Epub 2017 Feb 13.
5
Mechanisms of heparanase inhibitors in cancer therapy.硫酸乙酰肝素酶抑制剂在癌症治疗中的作用机制。
Exp Hematol. 2016 Nov;44(11):1002-1012. doi: 10.1016/j.exphem.2016.08.006. Epub 2016 Aug 26.
6
Genesis of placental sequestration in malaria and possible targets for drugs for placental malaria.胎盘隔离的疟疾起源和胎盘疟疾药物的可能靶点。
Birth Defects Res. 2019 Jun 1;111(10):569-583. doi: 10.1002/bdr2.1496. Epub 2019 Mar 28.
7
Heparanase regulates levels of syndecan-1 in the nucleus.乙酰肝素酶调节细胞核中Syndecan-1的水平。
PLoS One. 2009;4(3):e4947. doi: 10.1371/journal.pone.0004947. Epub 2009 Mar 23.
8
Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression.肝素酶增强的 syndecan-1 的脱落及其在驱动疾病发病机制和进展中的作用。
J Histochem Cytochem. 2020 Dec;68(12):823-840. doi: 10.1369/0022155420937087. Epub 2020 Jul 6.
9
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.肝素酶增强骨髓瘤细胞脱落连接蛋白-1 促进内皮细胞浸润和血管生成。
Blood. 2010 Mar 25;115(12):2449-57. doi: 10.1182/blood-2009-07-234757. Epub 2010 Jan 22.
10
Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.乙酰肝素酶-乙酰肝素硫酸轴的生物学及其在疾病发病机制中的作用。
Semin Thromb Hemost. 2021 Apr;47(3):240-253. doi: 10.1055/s-0041-1725066. Epub 2021 Apr 1.

引用本文的文献

1
The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue-Specific Perspectives.乙酰肝素酶的病理生理功能:从进化、结构和组织特异性角度探讨
FASEB J. 2025 Sep 15;39(17):e70976. doi: 10.1096/fj.202501859R.
2
Mechanisms of breast cancer metastasis: the role of extracellular matrix.乳腺癌转移的机制:细胞外基质的作用
Mol Cell Biochem. 2025 May;480(5):2771-2796. doi: 10.1007/s11010-024-05175-x. Epub 2024 Dec 9.
3
Quantitative proteomics and multi-omics analysis identifies potential biomarkers and the underlying pathological molecular networks in Chinese patients with multiple sclerosis.
定量蛋白质组学和多组学分析鉴定中国多发性硬化症患者潜在的生物标志物和潜在的病理分子网络。
BMC Neurol. 2024 Oct 31;24(1):423. doi: 10.1186/s12883-024-03926-3.
4
Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study.低分子量肝素钙治疗与脓毒症严重急性肾损伤预后的关系:孟德尔随机分析与回顾性研究
Front Pharmacol. 2024 Jun 10;15:1389354. doi: 10.3389/fphar.2024.1389354. eCollection 2024.
5
CD138 as a Specific CSF Biomarker of Multiple Sclerosis.CD138 作为多发性硬化症的特异性 CSF 生物标志物。
Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200230. doi: 10.1212/NXI.0000000000200230. Epub 2024 Apr 25.
6
Lack of Syndecan-1 promotes the pathogenesis of experimental rheumatoid arthritis.缺乏 Syndecan-1 可促进实验性类风湿关节炎的发病机制。
Immunogenetics. 2024 Jun;76(3):145-154. doi: 10.1007/s00251-024-01337-9. Epub 2024 Mar 7.
7
Prognostic Value of Antithrombin Activity Levels in the Early Phase of Intensive Care: A 2-Center Retrospective Cohort Study.重症监护早期抗凝血酶活性水平的预后价值:一项 2 中心回顾性队列研究。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218711. doi: 10.1177/10760296231218711.
8
Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma.重新审视Syndecans:乳腺癌中具有预后和可靶向治疗价值的主要信号调节因子
Cancers (Basel). 2023 Mar 16;15(6):1794. doi: 10.3390/cancers15061794.
9
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.肿瘤进展和免疫逃逸中的细胞外基质重塑:从机制到治疗。
Mol Cancer. 2023 Mar 11;22(1):48. doi: 10.1186/s12943-023-01744-8.
10
A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression.乙酰肝素酶/多配体蛋白聚糖1/神经生长因子的正反馈回路调节癌症疼痛进展。
Korean J Pain. 2023 Jan 1;36(1):60-71. doi: 10.3344/kjp.22277. Epub 2022 Dec 20.